Mood Disorders

 

Valproic Acid: Overused in Bipolar Disorder?

July 28, 2020

Valproate/divalproex appears to be considerably overused in the US; the use of lithium, second-generation antipsychotics, and carbamazepine should be more prominent in treatment decisions for patients with bipolar mania.

A Novel Approach to Contact Tracing

June 11, 2020

COVID-19 has spurred many changes leading to wider adoption of various technologies to support public health efforts. But even data collected for the greater good can have unintended negative or punitive consequences.

Celebrating Progress, but Challenges Remain

January 30, 2020

With their early age of onset, high prevalence, chronicity, and pervasive impact on multiple domains of functioning, the burden of mood disorders exceeds that of virtually all medical conditions in the US and globally in terms of disability, cost, and suffering.

Mania and Hypomania: The Latest Thinking on Duration of Episodes and Other Features

October 29, 2019

An international task force of experts in the diagnosis and treatment of bipolar disorder was recently convened to address concerns about DSM-5 criteria, particularly the definitions of manic episodes. The DSM’s duration criteria is an area of concern.

Mixed Features, Suicide, and Adolescents at Risk

September 26, 2019

Assessment of suicidal risk in adolescents is a solemn professional obligation that involves obtaining as much information as possible from family members or caregivers. Evaluation of mood disorders is an essential part of the assessment.